信利國際(00732.HK)預計年度綜合溢利大幅增加約6倍至5億港元以上
格隆匯3月24日丨信利國際(00732.HK)公佈,相較截至2018年12月31日止年度的公司擁有人應占經審核綜合溢利(約7400萬港元),預期截至2019年12月31日止年度的公司擁有人應占未經審核綜合溢利將會大幅增加約6倍至5億港元以上。
公司於2019年度擁有人應占未經審核綜合溢利預期增加的歸因於以下原因:分佔聯營公司虧損大幅減少與2018年約4.44億港元相比,2019大幅減少約4.2億港元至2400萬港元,主要歸因於集團主要聯營公司信利(惠州)智能顯示有限公司的財務和經營業績顯著改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.